The plant in Kabul, Afghanistan, is proving to be a significant contributor in the regional supply network for Abacavir Sulphate drug substance. This regional manufacturing capacity represents a notable step onward for the Afghan pharmaceutical industry and offers a unique opportunity to mitigate